I.2 Latin America and the Caribbean: population fully vaccinated against COVID-19, as of 31 August 2021 or latest available date

within the region is also uneven. Whereas in South America, 26.8% of the population had been fully vaccinated, in Central America the proportion was a mere 12.8%, and in the Caribbean, excluding Haiti, 14.6% (see figure I.2).

Figure I.2 Latin America and the Caribbean: population fully vaccinated against COVID-19, as of 31 August 2021 or latest available date

Uruguay Chile Ecuador Dominican Rep. El Salvador Saint Kitts and Nevis Panama Cuba Antigua and Barbuda Barbados Argentina Brazil Colombia Trinidad and Tobago Dominica Mexico Peru Paraguay Costa Rica Bolivia (Plur. State of) Suriname Guyana Belize Grenada Saint Lucia Bahamas Honduras Venezuela (Bol. Rep. of) Saint Vincent and the Grenadines Guatemala Jamaica Nicaragua Haiti 0

0 6.9 4.9 3.0 9.2 17.3 16.4 15.1 14.5 13.0 11.6 26.3 25.0 24.7 23.7 23.4 22.8 20.4 37.3 34.6 34.5 32.8 31.6 29.7 28.7 28.4 28.1

42.5 42.3 40.6

10 20 30 40 49.3

50 60 72.0 71.1

70 80

Source: Economic Commission for Latin America and the Caribbean (ECLAC), on the basis of Our World in Data [online] www.ourworldindata.org. Note: Record for countries reporting the breakdown of administration of first and second doses.

Despite the great progress made in some countries, it is estimated that, if current conditions of access to vaccines continue, the region as a whole will not be able to vaccinate 70% of the population by the end of 2021. In other words, the region is facing a supply problem, with countries falling into three groups depending on the pace at which the vaccination process can proceed. A first group of 10 countries could fully vaccinate 70% of their population between the end of 2021 and mid-2022. A second group of 9 countries will reach this point at the end of 2022, while a third group of 14 countries will not do so until 2023 (see map 1). This projection represents a more optimistic scenario than was estimated in April 2021: the number of countries that could vaccinate 70% of their population between the end of 2021 and mid-2022 has doubled, and the number that will not reach this goal until 2023 has fallen from 22 to 14.